SKYSONA® (elivaldogene autotemcel)
| Full Name | SKYSONA® (elivaldogene autotemcel) |
| Drug | elivaldogene autotemcel |
| Manufacturer | Genetix Biotherapeutics Inc. |
| Route of Administration | Intravenous |
| Site of Care | Healthcare Facility |
| Approved Indication | Indicated to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD) without an available human leukocyte antigen (HLA)-matched donor for allogeneic hematopoietic stem cell transplant |
| Disease | Cerebral Adrenoleukodystrophy (CALD) |
| Therapeutic Area | Neurology; Cell & Gene Therapy |
| Enrollment Information | Visit skysona.com |
| Phone Number | 847-849-1588 |
| Fax Number | 877-860-1726 |
| Website | skysona.com |